PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 161 filers reported holding PORTOLA PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.44 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $2,521,000 | -7.1% | 94,000 | -6.0% | 0.53% | -0.4% |
| Q2 2019 | $2,713,000 | -21.8% | 100,000 | 0.0% | 0.53% | -24.4% |
| Q1 2019 | $3,469,000 | +493.0% | 100,000 | +233.3% | 0.70% | +309.9% |
| Q4 2018 | $585,000 | -12.0% | 30,000 | +20.0% | 0.17% | +44.5% |
| Q3 2018 | $665,000 | -86.1% | 25,000 | -80.3% | 0.12% | -87.1% |
| Q2 2018 | $4,797,000 | +30.0% | 127,000 | +12.4% | 0.92% | -27.1% |
| Q1 2018 | $3,691,000 | +8.3% | 113,000 | +61.4% | 1.26% | -4.0% |
| Q4 2017 | $3,408,000 | +8.7% | 70,000 | +20.7% | 1.32% | +46.3% |
| Q3 2017 | $3,134,000 | +458.6% | 58,000 | +110.9% | 0.90% | +165.5% |
| Q1 2016 | $561,000 | -83.5% | 27,500 | -58.3% | 0.34% | -80.6% |
| Q4 2015 | $3,396,000 | -37.8% | 66,000 | -48.4% | 1.75% | -34.7% |
| Q3 2015 | $5,456,000 | +22.2% | 128,000 | +30.6% | 2.68% | +33.1% |
| Q2 2015 | $4,464,000 | +32.1% | 98,000 | +10.1% | 2.01% | -10.9% |
| Q1 2015 | $3,379,000 | – | 89,000 | – | 2.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fernwood Investment Management, LLC | 228,873 | $7,475,000 | 4.17% |
| PFM Health Sciences, LP | 5,326,671 | $173,969,000 | 3.54% |
| Marcus Capital, LLC | 22,950 | $750,000 | 2.76% |
| Partner Investment Management, L.P. | 72,284 | $2,361,000 | 2.55% |
| CADIAN CAPITAL MANAGEMENT, LP | 1,240,944 | $40,529,000 | 2.19% |
| HARVEY CAPITAL MANAGEMENT INC | 158,580 | $5,179,000 | 1.94% |
| SECTORAL ASSET MANAGEMENT INC | 498,412 | $16,278,000 | 1.78% |
| Everett Capital Advisors UK LLP | 551,173 | $18,001,000 | 1.52% |
| ROSENBLUM SILVERMAN SUTTON S F INC /CA | 125,210 | $4,089,000 | 1.46% |
| Atika Capital Management LLC | 113,000 | $3,691,000 | 1.26% |